vTv Therapeutics (VTVT) Interest & Investment Income (2016 - 2026)
vTv Therapeutics (VTVT) reported Interest & Investment Income of $838000.0 for Q1 2026, up 153.17% on a YoY basis from $331000.0 in Q1 2025, and down 3.12% sequentially from $865000.0 in Q4 2025.
vTv Therapeutics (VTVT) Interest & Investment Income (2016 - 2026) Analysis & Trends
vTv Therapeutics (VTVT) has 11 years of Interest & Investment Income data on file, last reported at $838000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 153.17% year-over-year to $838000.0; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 30.82% YoY), and the FY2025 full-year result was $1.9 million, up 19.49% from the prior year.
- Interest & Investment Income fell to $838000.0 in Q1 2026, from $865000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $865000.0 in Q4 2025 to a low of $50000.0 in Q2 2022.
- A 5-year average of $318562.5 and a median of $214000.0 in 2023 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 387.5% in 2024 and plunged 50.27% in 2025, its largest moves.
- Tracing VTVT's Interest & Investment Income over 5 years: stood at $152000.0 in 2022, then plunged by 42.11% to $88000.0 in 2023, then jumped by 387.5% to $429000.0 in 2024, then jumped by 101.63% to $865000.0 in 2025, then decreased by 3.12% to $838000.0 in 2026.
- Business Quant data shows VTVT's Interest & Investment Income at $838000.0 in Q1 2026, $865000.0 in Q4 2025, and $399000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | vTv Therapeutics | 19.21 Mn | 19.21 Mn | - | 838,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 838,000.00 |
| Dec 31, 2025 | 865,000.00 |
| Sep 30, 2025 | 399,000.00 |
| Jun 30, 2025 | 275,000.00 |
| Mar 31, 2025 | 331,000.00 |
| Dec 31, 2024 | 429,000.00 |
| Sep 30, 2024 | 504,000.00 |
| Jun 30, 2024 | 553,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 88,000.00 |
| Sep 30, 2023 | 131,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 152,000.00 |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 50,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2020 | 12,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Sep 30, 2019 | 15,000.00 |